Clinical-epidemiological behavior of post-COVID-19 syndrome in patients at Andrés Ortiz Polyclinic, 2021
Keywords:
COVID-19, Convalescence, Signs and Symptoms, Post-COVID-19 Syndrome.Abstract
Introduction: post-COVID-19 syndrome is the set of signs and symptoms that develop during or after an infection compatible with COVID-19, that persist for more than 12 weeks and are not explained by an alternative diagnosis.
Objective: to characterize the clinical-epidemiological behavior of the post-COVID-19 syndrome in patients at the Andrés Ortiz Polyclinic.
Method: a descriptive and cross-sectional observational study was carried out from October to December 2021, in a population of 51 subjects that was studied in its entirety. The analysis was descriptive.
Results: patients with 50-59 years (n = 20; 39.2%), female (n = 32; 62.7%) predominated. The most frequently affected organ system was the respiratory (n = 19; 37.2%), while the symptoms were: chronic fatigue (n = 15; 29.4%), shortness of breath (n = 11; 21.5%) and cough (n = 8, 15.6%). Among the patients with respiratory (n = 30), cardiovascular (n = 24) and neurological (n = 10) diseases, the most frequent were, respectively: pulmonary fibrosis (n = 17; 56.7%), cardiac arrhythmias (n = 11; 45.8%) and peripheral neuropathies (n = 5; 50%).
Conclusions: post-COVID-19 syndrome occurred mainly between the ages of 50 and 59, in female patients, with symptoms of chronic fatigue, shortness of breath and cough, as well as pulmonary fibrosis, cardiac arrhythmias and peripheral neuropathies as main comorbidities
References
2. Gutiérrez Bautista D, Mosqueda Martínez EE, Joaquin Vilchis H, Morales Fernández JA, Cruz Salgado AX; Chávez Aguilar JE, et al. Efectos a largo plazo de la COVID-19: una revisión de la literatura. Act Med [Internet]. 2021 [citado 18/05/2022];19(3):421-428. Disponible en https://www.scielo.org.mx.actmed.
3. NICE panel expert. COVID-19 rapid guideline: managing the long-term effects of COVID-19. [Internet]. 2020 [citado 18/05/2022];18(3):23-31. Disponible en https://www.nice.org.uk.nicepanelexpert.
4. Bouza E, Cantón Moreno R, De Lucas Ramos P, García-Botella A, García-Lledó A, Gómez-Pavón J, et al. Síndrome post-COVID: Un documento de reflexión y opinión. Rev Esp Quimioter [Internet]. 2021 [citado 18/05/2022];34(4):272-273. Disponible https://www.ncbi.nlm.nih.gov.doi:10.37201/req/023.2021
5. Tenforde M, Kim S, Lindsell C, Billig Rose E, Shapiro N, Files D, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems NetworkUnited States. MMWR Morb Mortal Wkly Rep [Internet]. 2020 [citado18/05/2022];69(30):993-98. Disponible en https://www.pubmed.ncbi.nlm.nih.gov.mwtenforde2020
6. Espinosa-Brito, Alfredo. A propósito de la definición clínica oficial de la enfermedad pos-COVID por la OMS. Medisur [Internet]. 2022 [citado 18/05/2022];20(1):14. Disponible en https://www.medisur.sld.cu/index/php/medisur/article/view/5337
7. Evans R, McAuley H, Harrison E, Shikotra A, Singapuri A, Sereno M et al. Physical, cognitive and mental health impacts of COVID-19 following hospitalization-a multi-centre prospective cohort study. Lancet Respir Med [Internet]. 2021 [citado 18/05/2022];19(1):11-13. Disponible en https://doi.org/10.1101/2021.03.22.21254057
8. NIHR: Living with Covid19 - Second review. [Internet]. 2021 [citado 18/05/2022];18(1):13. Disponible en https://evidence.nihr.ac.uk.doi:10.3310/themereview_41169
9. Prieto MA, Prieto O, Castro HM. Covid prolongado: estudio de cohorte transversal. Rev Fac Cien Med Univ Nac Cordoba [Internet]. 2021 [citado 18/05/2022];78(1):33–36. Disponible en https://revistas.unc.edu.ar.estudiodecohortetransversal
10. Dore GJ, Cysique L, Wilhelm KA, Andresen D, Tonga K, Stone E, et al. Persistent symptoms up to 4 months after community and hospital- managed SARS-CoV-2 infection. Med Journal Australia [Internet]. 2020 [citado18/05/2022];21(2):5-7. Disponible en https://pubmed.ncbi.nlm.nih.gov.doi:10.5694/mja2.59963
11. Hierrezuelo Rojas N, Cardero Castilo F, Carbó Cisnero Y. Síndrome post-COVID en pacientes con enfermedad por coronavirus. Rev cubana med [Internet]. 2022 [citado 18/05/2022];61(1):4-6. Disponible en http://creativecommons.org/licenses/by-nc/4.0/deed.es_ES
12. Díaz Y,Tejeda E, Díaz EG, Santiago W, Oyarzabal A, Calderón N. Caracterización clínica y epidemiológica de pacientes con la COVID-19. Rev Cubana de Med Mil [Internet]. 2021 [citado 18/05/2022];50(1):4-5. Disponible en http://www.revmedmilitar.sld.cu/index/php/revmedmilitar/article/view
13. Muller MP, de Jager J, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med [Internet]. 2020 [citado 18/05/2022];167(12):1312-20. Disponible en https://archintermed.com/index/php/archintermed/article/view
14. Tyagi SC, Singh M. Daño multiorgánico por Covid-19: insuficiencia cardíaca congestiva (cardiopulmonar) y fuga de la barrera hemato-cardíaca. Rev corsalud [Internet]. 2021 [citado 18/05/2022];476(4):1891-1895. Disponible en https://www.revcorsalud.sld.cu/index/php/revcorsalud/article/view
15. Farak Gómez J. Síndrome post COVID 19 ¿de qué se trata? iMedPub Journals [Internet]. 2021 [citado 18/05/2022];17(5):1. Disponible en https://www.archivosdemedicina.com/index/php/archivosdemedicina/article/view
16. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet [Internet] 2021 [citado 18/05/2022];397(10270):220-232. Disponible en https://doi:10.1016/S0140-6736(20)32656-8
17. Guler SA, Ebner L, Beigelman C, Bridevaux PO, Brutsche M, Clarenbach C, et al. Pulmonary function and radiological features four months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J [Internet]. 2021[citado 18/05/2022];25(1):9-12. Disponible en https://doi.org/10.1183/13993003.03690.2020
18. Elias Armas KS, Pérez Mola K, Batista Cuenca M. El sistema cardiovascular y el daño inducido por el coronavirus 2. Rev cubana med [Internet]. 2021 [citado 18/05/2022];60(2):4. Disponible en https://www.revmedicina.sld.cu/index/php/revmedicina/article/view
19. Pérez Cabrera LA, Planas Sliuntiaeva NL, Aroche Aportela R. Miocarditis post-Covid: a propósito de un caso tratado con Jusvinza. Invest Medicoquir [Internet]. 2021 [citado 18/05/2022]; 13(supl.):2. Disponible en https://www.revcimeq.sld.cu/index/php/revcimeq/article/view
20. Piñera-Castro HJ. COVID-19 and Guillain-Barré Syndrome: A fortuitous relationship? Rev mex neurocienc [Internet]. 2020 [citado 18/05/2022];21(5):205-2014. Disponible en https://doi.org/10.24875/rmn.20000079
21. Needham E, Newcombe V, Michell A, Thornton R, Grainger A, Anwar F, et al. Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19. J Neurol [Internet]. 2020 [citado 18/05/2022];268: 2685–9. Disponible en: https://link.springer.com/article/10.1007/s00415-020-10321-8
Downloads
Published
How to Cite
Issue
Section
License
Those authors who have publications with this journal, accept the following terms:
The authors will retain their copyright and guarantee the journal the right of first publication of your work, which will be under a Creative license Commons Attribution-NonCommercial-ShareAlike 4.0 International . (CC BY-NC-SA 4.0).
The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (eg:deposit it in an institutional telemat
